Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mmuL)

Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy

Medicine ◽

10.1097/md.0000000000002844 ◽

2016 ◽

Vol 95 (9) ◽

pp. e2844 ◽

Cited By ~ 24

Author(s):

Sumanth Karamchand ◽

Rory Leisegang ◽

Michael Schomaker ◽

Gary Maartens ◽

Lourens Walters ◽

...

Keyword(s):

Risk Factors ◽

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Incident Diabetes ◽

First Line ◽

Nonnucleoside Reverse Transcriptase Inhibitor Resistance Among Antiretroviral-Naive HIV-Positive Pregnant Women

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/00126334-200302010-00006 ◽

2003 ◽

Vol 32 (2) ◽

pp. 153-156 ◽

Cited By ~ 9

Author(s):

Salome N. Juethner ◽

Catherine Williamson ◽

Maria B. Ristig ◽

Pablo Tebas ◽

Warren Seyfried ◽

...

Keyword(s):

Reverse Transcriptase ◽

Pregnant Women ◽

Transcriptase Inhibitor ◽

Hiv Positive ◽

Inhibitor Resistance ◽

Maintenance of Naive and Th1 CD4 Phenotype and Lack of CD8 Activation in Patients Switching From Protease Inhibitors to Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Regimens

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/00126334-200112010-00017 ◽

2001 ◽

Vol 28 (4) ◽

pp. 401-403 ◽

Cited By ~ 1

Author(s):

Luca Meroni ◽

Daniele Manganaro ◽

Stefania Varchetta ◽

Nadia Gatti ◽

Agostino Riva ◽

...

Keyword(s):

Reverse Transcriptase ◽

Protease Inhibitors ◽

Transcriptase Inhibitor ◽

Maintenance of Naive and Th1 CD4 Phenotype and Lack of CD8 Activation in Patients Switching From Protease Inhibitors to Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Regimens

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/00042560-200112010-00017 ◽

2001 ◽

Vol 28 (4) ◽

pp. 401-403

Author(s):

Luca Meroni ◽

Daniele Manganaro ◽

Stefania Varchetta ◽

Nadia Gatti ◽

Agostino Riva ◽

...

Keyword(s):

Reverse Transcriptase ◽

Protease Inhibitors ◽

Transcriptase Inhibitor ◽

Altered Pharmacokinetics of Indinavir by a Novel Nonnucleoside Reverse Transcriptase Inhibitor (HBY-097): A Pharmacokinetic Evaluation in HIV-Positive Patients

The Journal of Clinical Pharmacology ◽

10.1177/00912709922011746 ◽

1999 ◽

Vol 39 (10) ◽

pp. 1085-1093 ◽

Cited By ~ 6

Author(s):

Sandra Hayashi ◽

Deepthi Jayesekera ◽

Anura Jayewardene ◽

Anita Shah ◽

Lourdes Thevanayagam ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Positive ◽

Reverse Transcriptase Inhibitor ◽

Pharmacokinetic Evaluation

Short Communication: Nonnucleoside Reverse Transcriptase Inhibitor Fold Change or Plasma Concentration as a Predictor of Virological Response over 48 Weeks in Highly Treatment Experienced HIV-Positive Individuals

AIDS Research and Human Retroviruses ◽

10.1089/aid.2006.22.338 ◽

2006 ◽

Vol 22 (4) ◽

pp. 338-341

Author(s):

Alan Winston ◽

Janaki Amin ◽

Gill Hales ◽

David A. Cooper ◽

Sean Emery

Keyword(s):

Plasma Concentration ◽

Reverse Transcriptase ◽

Virological Response ◽

Short Communication ◽

Transcriptase Inhibitor ◽

Fold Change ◽

Hiv Positive ◽

Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor–based or nonnucleoside reverse transcriptase inhibitor–based antiretroviral therapy

American Journal of Clinical Nutrition ◽

10.1093/ajcn/82.1.146 ◽

2005 ◽

Vol 82 (1) ◽

pp. 146-154 ◽

Cited By ~ 3

Author(s):

Asha Thomas-Geevarghese ◽

Subhashree Raghavan ◽

Robert Minolfo ◽

Steve Holleran ◽

Rajasekhar Ramakrishnan ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Positive ◽

Postprandial Response ◽

Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma - drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s002800050932 ◽

1999 ◽

Vol 43 (6) ◽

pp. 516-519 ◽

Cited By ~ 19

Author(s):

Vinodh R. Nannan Panday ◽

Richard M. W. Hoetelmans ◽

Rolf P. G. van Heeswijk ◽

Pieter L. Meenhorst ◽

Marijke Inghels ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Case Report ◽

Drug Interactions ◽

Reverse Transcriptase ◽

Protease Inhibitors ◽

Transcriptase Inhibitor ◽

Immunodeficiency Virus ◽

Reverse Transcriptase Inhibitor ◽

Human Immunodeficiency Virus 1

Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor–based or nonnucleoside reverse transcriptase inhibitor–based antiretroviral therapy

American Journal of Clinical Nutrition ◽

10.1093/ajcn.82.1.146 ◽

2005 ◽

Vol 82 (1) ◽

pp. 146-154

Author(s):

Asha Thomas-Geevarghese ◽

Subhashree Raghavan ◽

Robert Minolfo ◽

Steve Holleran ◽

Rajasekhar Ramakrishnan ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Positive ◽

Postprandial Response ◽

Initial highly-active antiretroviral therapy with a protease inhibitor versus a nonnucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect metaanalyses

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70040-3 ◽

2007 ◽

Vol 2007 ◽

pp. 61-62

Author(s):

D.R. Snydman

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Highly Active Antiretroviral Therapy ◽

Transcriptase Inhibitor ◽

Highly Active ◽